PL Planet Labs PBC
Price Chart
Executive Summary
Planet Labs PBC entered into an Equity Distribution Agreement to sell up to $1.5 billion of Class A common stock through an at-the-market (ATM) offering, with options for direct sales and forward sale agreements. This filing formalizes the ATM program disclosed in the prior day's 424B5 prospectus supplement, confirming the massive potential dilution of ~10% of market cap at current prices.
Key Financial Metrics
Actionable Insight
The formalization of the $1.5B ATM facility confirms aggressive capital raising despite strong recent operational momentum. Monitor actual share sales through quarterly filings — if the full amount is drawn, dilution will be substantial. The forward sale structure allows the company to defer cash receipt and potentially reduce immediate dilution, but the overhang remains significant.
Key Facts
- Planet Labs entered into an Equity Distribution Agreement on June 5, 2026 for up to $1,500,000,000 in Class A common stock
- The agreement includes both direct ATM sales through 16 sales agents and forward sale agreements with Goldman Sachs Bank USA and Citibank, N.A.
- Sales agents receive commissions up to 2.0% of gross proceeds; forward sellers receive up to 2.0% of the volume-weighted average sales price
- The offering is registered under a shelf registration statement on Form S-3 filed and effective June 5, 2026
- This filing follows a 424B5 filed the same day for the same $1.5B ATM offering, confirming the capital raise is proceeding
- The $1.5B offering represents approximately 10% of Planet Labs' $15.5B market capitalization
Financial Impact
Up to $1,500,000,000 in potential equity issuance, representing ~10% dilution of current market cap
Risk Factors
- Massive potential dilution of ~10% of outstanding shares if the full $1.5B is sold
- ATM sales can be executed at management's discretion, creating persistent overhang
- Forward sale agreements introduce complexity and potential for additional share issuance if stock price falls below floor prices
- The offering comes immediately after strong earnings, suggesting opportunistic timing rather than distress
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-024109 |
| Document: ef20075554_8k.htm | 0001140361-26-024109 |
| Document: ef20075554_ex5-1.htm | 0001140361-26-024109 |
| Document: 0001140361-26-024109-index-headers.html | 0001140361-26-024109 |
| Document: 0001140361-26-024109-index.html | 0001140361-26-024109 |
| Document: 0001140361-26-024109.txt | 0001140361-26-024109 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $31.77 awaiting T+1 | awaiting T+1 | — | $31.15 (−1.95%) |
|
Jun 5, 2026
9d ago
|
8-K
| $39.95 awaiting T+1 | awaiting T+1 | — | $31.15 (+22.03%) |
|
Jun 5, 2026
9d ago
|
424B5
| $41.56 awaiting T+1 | awaiting T+1 | — | $31.15 (+25.05%) |
|
Jun 5, 2026
9d ago
|
S-3ASR
| $42.50 awaiting T+1 | awaiting T+1 | — | $31.15 (−26.71%) |
|
Jun 5, 2026
9d ago
|
10-K/A
| $41.50 awaiting T+1 | awaiting T+1 | — | $31.15 (−24.94%) |
|
Jun 4, 2026
10d ago
|
8-K
| $44.97 awaiting T+1 | awaiting T+1 | — | $31.15 (−30.73%) |
|
May 29, 2026
16d ago
|
DEFA14A
| $51.14 $46.46 | ▼ −9.15% | ▼ −9.43% | $31.15 (−39.09%) |
|
May 4, 2026
5w ago
|
8-K
| $37.13 $39.69 | ▲ +6.89% | ▲ +5.51% | $31.15 (−16.11%) |
|
Apr 27, 2026
6w ago
|
25-NSE
| $23.71 $23.71 | · 0.00% | ▲ +0.49% | $31.15 (+31.38%) |
|
Apr 15, 2026
8w ago
|
144
| — | awaiting T+1 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access